The Rheumatology Network gout clinical focus page provides information on the latest gout news, study and clinical trial findings, and clinical guideline updates. We feature expert interviews with leading physicians and investigators, articles, videos, podcasts, and breaking FDA approvals for gout drugs.
December 31, 2022
Take a few minutes to review the most noteworthy studies published on Rheumatology Network in 2022.
December 24, 2022
Take 5 minutes to catch up on Rheumatology Network's top articles from December 2022.
December 23, 2022
Theodore Fields, MD, FACP, discusses the most important gout studies in 2022, regulatory news, and the most pressing issues surrounding gout moving into 2023.
December 08, 2022
The incidence of gout, the most common type of inflammatory arthritis in men, has increased globally in recent decades.
December 01, 2022
Results indicated that the incidence of osteoporosis increased up to 4 times in younger male patients with gout when compared with those without gout.
November 13, 2022
There was also a reduction in ultrasound features of gout at the knee identified, with improvement found in 63% of the tight control group and 14% of the conventional group.
November 12, 2022
Exposure to more than 100 mg was linked to significantly lower odds ratios for first-ever ACS event for women.
November 08, 2022
Abdul Abdellatif, MD, FASN, explains the results of the MIRROR RCT trial, in which the renal function of patients with gout receiving pegloticase plus methotrexate co-therapy was evaluated.
November 01, 2022
"It may be important to identify genetic variants from a gout genome-wide association study (GWAS) rather than serum urate GWAS, in case these variants have an effect on gout independent of their effect on serum urate.”
October 28, 2022
Investigators concluded febuxostat should still be used cautiously for patients with gout and cardiovascular diseases due to inconclusive results.